Rosiglitazone structure
Rosiglitazone
Rosiglitazone is a type of thiazolidinedione antidiabetics. Thiazolidinedione are agonists for peroxisome-proliferator–activated receptor γ (PPAR-γ). PPAR-γ receptors are ligand-activated nuclear transcription factors that modulate gene expression, lowering blood glucose primarily by increasing insulin sensitivity in peripheral tissues. Rosiglitazone is widely used to lower blood glucose levels in patients with type 2 diabetes mellitus.
Find 3 Related Holders
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
1995-07-26 -
Country:
China -
Address:
Lianyungang Economic and Technological Development Zone, Jiangsu Province -
Tax NO.:
913207006083959289 -
Registered Funds:
1,000,000,000 Yuan -
Website:
-
Email:
Chengdu Hengrui Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
2001-03-07 -
Country:
China -
Address:
No. 18, Baicao Road, West Park, Chengdu Hi-tech Zone -
Tax NO.:
91510100727431952L -
Registered Funds:
29.18 million yuan -
Website:
-
Email:
MYLAN LABORATORIES LTD
United States
United States
API Registration Country
API Inactive
-
Country:
United States -
Email:
Recommended Suppliers of Rosiglitazone
-
Hainan Flying International Trade Co., L
CN1 YR
Contact Supplier -
Wuhan Pnq Int Trade Co., Ltd
CN1 YR
Contact Supplier -
Guangzhou Yaoguang Technology Co., Ltd.
CN1 YR
Contact Supplier -
Xian ZB Biotech Co.,Ltd
CN1 YR
Contact Supplier -
Xi'an Xszo Chem Co., Ltd.
CN1 YR
Contact Supplier